POSA423 Healthcare Resource Utilization (HRU) Survey to Inform HRU Data Collection Alongside the Double-Blinded Trilynx Study Evaluating Xevinapant in Combination with Chemoradiotherapy Versus Placebo Plus Chemoradiotherapy in Patients with ...
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.1325
https://www.valueinhealthjournal.com/article/S1098-3015(21)03120-X/fulltext
Title :
POSA423 Healthcare Resource Utilization (HRU) Survey to Inform HRU Data Collection Alongside the Double-Blinded Trilynx Study Evaluating Xevinapant in Combination with Chemoradiotherapy Versus Placebo Plus Chemoradiotherapy in Patients with ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)03120-X&doi=10.1016/j.jval.2021.11.1325
First page :
Section Title :
Open access? :
No
Section Order :
10869